glp-1 pancreas Risk of pancreatic cancer associated with receptor agonist therapy The Ultimate Guide to GLP-1:

Epub 2016 Jun 13

How do SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compare in reducing #mortality and #cardiovascular events in patients with type 2 #diabetes

Orforglipron is the first small-molecule GLP-1 receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial

In this class, we're seeing less of the big three heart outcomes, which is heart attack, stroke, and cardiovascular death

Patent expiration of major GLP-1 drugs is also expected to fuel market expansion in the coming years

Hoffmann-La Roche AG acquired Carmot Therapeutics for $2.7 billion, gaining access to Carmot's therapies for obesity and diabetes, including GLP-1 receptor agonists